Post-translational Processing of Tumor Necrosis Factor Production
スポンサーリンク
概要
- 論文の詳細を見る
To elucidate the mechanism of tumor necrosis factor (TNF) production, we analyzed proteins produed in macrophages sharing the epitope of TNF according to the priming and triggering of TNF production. Rabbit alveolar macrophages primed with Bacillus Calmette-Guerin (BCG) were isolated and cultured in vitro with ^<35>S-methionine, and the proteins produced were analyzed using anti-rabbit TNF monoclonal antibody. Primed with BCG, alveolar macrophages synthesized two proteins with molecular sizes of 50 and 17 kilodaltons (kDa) (p50 and p17) sharing the same epitope with mature TNF within the cells. These two proteins were released into the medium where other proteins were detected without TNF-activity. Cultured with lipopolysaccharide (LPS triggering), the primed alveolar macrophages released TNF-activity into the medium where p17 together with many larger proteins was detected by immunoprecipitation. In vitro translation of messenger ribonucleic acid (mRNA) from BCG-primed macrophages showed that primary TNF has a molecular size of 28 kDa (p28). These results suggest that active TNF of p17 is secreted when triggered via post-translational processing of the precursor molecules synthesized through priming with BCG.
- 社団法人日本薬学会の論文
- 1991-02-25
著者
-
田辺 由幸
Biotechnology Research Center Teikyo University
-
杣 源一郎
Biotechnology Research Center Teikyo University
-
杣 源一郎
帝京大生物工学研究センター
-
田辺 浪子
Biotechnology Research Center, Teikyo University
-
森川 明信
Biotechnology Research Center, Teikyo University
-
水野 伝一
Biotechnology Research Center, Teikyo University
-
水野 伝一
Biotechnology Research Center Teikyo University
-
田辺 浪子
帝京大学生物工学研究センター
-
田辺 浪子
Biotechnology Research Center Teikyo University
-
Morikawa A
Teikyo Univ. Kawasaki Jpn
-
森川 明信
Biotechnology Research Center Teikyo University
関連論文
- Post-translational Processing of Tumor Necrosis Factor Production
- 泌尿器癌患者におけるEET(endogenous and exogenous TNF)療法の試み : 副作用を中心に(第270回新潟地方会)
- Suppression of Hyperalgesia in Streptozotocin-Induced Diabetic Mice by a Lipopolysaccharide from Pantoea agglomerans
- Homeostasis as Regulated by Activated Macrophage. IX. Enhancement Effect of LPSw (a Lipopolysaccharide from Wheat Flour) on Hen Egg-Laying and Breaking Strength of Eggshell
- Homeostasis as Regulated by Activated Macrophage. VIII. LPSw (a Lipopolysaccharide from Wheat Fluor) Can Regulate Bone Resorption of Chick Embryo
- Homeostasis as Regulated by Activated Macrophage. VII. Suppression of Serum Cholesterol Level by LPSw (a Lipopolysaccharide from Wheat Flour) in WHHL (Watanabe Heritable Hyperlipidemic) Rabbit
- Homeostasis as Regulated by Activated Macrophage. VI. Protective Effect of LPSw (a Lipopolysaccharide from Wheat Fluor) against Acute Infection by Toxoplasma gondii in Mice
- Homeostasis as Regulated by Activated Macrophage. V. Suppression of Diabetes Mellitus in Non-obese Diabetic Mice by LPSw (a Lipopolysaccharide from Wheat Flour)
- Homeostasis as Regulated by Activated Macrophage. IV. Analgesic Effect of LPSw, a Lipopolysaccharide of Wheat Flour
- Homeostasis as Regulated by Activated Macrophage. III. Protective Effect of LPSw (Lipopolysaccharide (LPS) of Wheat Flour) on Gastric Ulcer in Mice as Compared with Those of Other LPS from Various Sources
- Homeostasis as Regulated by Activated Macrophage. II. LPS of Plant Origin Other than Wheat Flour and Their Concomitant Bacteria
- Homeostasis as Regulated by Activated Macrophage. I. Lipopolysaccharide (LPS) from Wheat Flour : Isolation, Purification and Some Biological Activities
- 323 大腸癌の肝・肺転移に対する r-TNF-S を使用した EET 療法と動注療法の検討(第36回日本消化器外科学会総会)
- 330 悪性腫瘍に対するTNF療法の臨床的, 基礎的研究
- 312 内因性TNF誘導療法の有用性に対する臨床的, 基礎的検討
- 242. 進行癌に対する内因性, 外因性腫瘍壊死因子 (TNF) 療法の試み
- 膀胱腫瘍細胞における人腫瘍壊死因子感受性試験 : 第74回日本泌尿器科学会総会
- 示-87 手術侵襲による宿主免疫機能低下に伴う細菌感染症と、このBRM 投与による防御効果に関する実験的検討(第42回日本消化器外科学会総会)
- 示2-249 術後の細菌感染抵抗性の低下における TNF の役割(第41回日本消化器外科学会総会)
- 示-70 rTNF-SとOK-432 の併用療法により肺、肝転移巣の縮小をみた大腸癌の1例(第34回日本消化器外科学会総会)
- 泌尿器癌患者に対するEET(endogenous and exogenous TNF)療法の試み : 有効症例を中心に(第272回新潟地方会)
- TNFの難治疾患治療への応用 (難治性疾患治療薬への挑戦--現状と展望)